Hematocrit Control ‘Suboptimal’ in More Than Half of Patients with Polycythemia Vera
Cecilia BrownMyeloproliferative Neoplasms | February 2, 2023
Hematocrit control was “suboptimal” in more than half of patients with high-risk polycythemia vera, and in nearly two-thirds of low-risk patients, according to a retrospective study. Srdan Verstovsek, MD, of the MD Anderson Cancer Center, and colleagues conducted the research and published their findings in Annals of Hematology. ...
Advertisement

Advertisement
Advertisement
Editorial Board

Expert Interviews

Knowledge Hubs

Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia

Trending on MashupMD

ACUTE MYELOID LEUKEMIA

October 12, 2022